Literature DB >> 14511752

GABA and glutamate receptors are involved in modulating pacemaker activity in hydra.

G Kass-Simon1, A Pannaccione, P Pierobon.   

Abstract

The effects of gamma-amino butyric acid (GABA) and glutamate, their ionotropic agonists and antagonists on hydra's ectodermal and endodermal pacemaker systems were studied. GABA decreased ectodermal body contraction bursts (CBs) and the number of pulses in a burst (P/CB) and endodermal rhythmic potentials (RPs); tentacle pulses (TPs) were not affected. The GABA(A) agonist, muscimol, and the benzodiazepine receptor agonist, diazepam, mimicked the effects of GABA on the endodermal system. The GABA(A) antagonist bicuculline counteracted GABA's effects. Low concentrations of glutamate increased CBs and RPs. Higher concentrations required concanavalin A (Con A) to produce the same effect on CBs and P/CB. TPs were increased by high concentrations of glutamate and kainate. The ionotropic glutamate agonist, alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) also required Con A to increase CBs and RPs. The effects of AMPA were antagonized by 6-nitro-7-sulfamoylbenzo[f]quinoxaline-2,3-dione (NBQX), which, per se, decreased CBs. The results indicate that GABA and glutamate, acting on their ionotropic receptors, modify the impulses of hydra's pacemaker systems. On the whole GABA decreased the outputs of both ectodermal and endodermal impulse generating systems, while glutamate increased them.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14511752     DOI: 10.1016/s1095-6433(03)00168-5

Source DB:  PubMed          Journal:  Comp Biochem Physiol A Mol Integr Physiol        ISSN: 1095-6433            Impact factor:   2.320


  12 in total

Review 1.  When and why amino acids?

Authors:  Kresimir Krnjević
Journal:  J Physiol       Date:  2009-10-12       Impact factor: 5.182

2.  Immunochemical Localization of GABAA Receptor Subunits in the Freshwater Polyp Hydra vulgaris (Cnidaria, Hydrozoa).

Authors:  A Concas; R Imperatore; F Santoru; A Locci; P Porcu; L Cristino; P Pierobon
Journal:  Neurochem Res       Date:  2016-07-23       Impact factor: 3.996

Review 3.  Diversity of Cnidarian Muscles: Function, Anatomy, Development and Regeneration.

Authors:  Lucas Leclère; Eric Röttinger
Journal:  Front Cell Dev Biol       Date:  2017-01-23

4.  Molecular characterization of larval development from fertilization to metamorphosis in a reef-building coral.

Authors:  Marie E Strader; Galina V Aglyamova; Mikhail V Matz
Journal:  BMC Genomics       Date:  2018-01-04       Impact factor: 3.969

5.  Spontaneous body contractions are modulated by the microbiome of Hydra.

Authors:  Andrea P Murillo-Rincon; Alexander Klimovich; Eileen Pemöller; Jan Taubenheim; Benedikt Mortzfeld; René Augustin; Thomas C G Bosch
Journal:  Sci Rep       Date:  2017-11-21       Impact factor: 4.379

6.  Hydra vulgaris exhibits day-night variation in behavior and gene expression levels.

Authors:  Hiroyuki J Kanaya; Yoshitaka Kobayakawa; Taichi Q Itoh
Journal:  Zoological Lett       Date:  2019-03-08       Impact factor: 2.836

7.  Neuroactive compounds induce larval settlement in the scleractinian coral Leptastrea purpurea.

Authors:  Mareen Moeller; Samuel Nietzer; Peter J Schupp
Journal:  Sci Rep       Date:  2019-02-19       Impact factor: 4.379

8.  Linalool acts as a fast and reversible anesthetic in Hydra.

Authors:  Tapan Goel; Rui Wang; Sara Martin; Elizabeth Lanphear; Eva-Maria S Collins
Journal:  PLoS One       Date:  2019-10-24       Impact factor: 3.240

Review 9.  Evolution of glutamatergic signaling and synapses.

Authors:  Leonid L Moroz; Mikhail A Nikitin; Pavlin G Poličar; Andrea B Kohn; Daria Y Romanova
Journal:  Neuropharmacology       Date:  2021-07-31       Impact factor: 5.273

10.  Early evolution of ionotropic GABA receptors and selective regimes acting on the mammalian-specific theta and epsilon subunits.

Authors:  Christopher J Martyniuk; Stéphane Aris-Brosou; Guy Drouin; Joel Cahn; Vance L Trudeau
Journal:  PLoS One       Date:  2007-09-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.